Nyxoah announces completion of its initial public offering on Nasdaq and full exercise of option to purchase additional shares by underwriters

REGULATED INFORMATION
INSIDER KNOWLEDGE

Nyxoah Announcements Completion of initial public offering on Nasdaq and Full exercise of the option by syndicate banks to buy additional shares

Mont-Saint-Guibert, Belgium – July 8th, 2021, 10:30thpm CET / 4:30thpI AND – Nyxoah SA (Euronext Brussels/ Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on developing and commercializing innovative solutions for the treatment of obstructive sleep apnea (OSA), today announced the completion of its initial public offering in the United States on July 7, 2021 states ( the “Offering”) of 2,835,000 shares of common stock at a price of $ 30 per share for total gross proceeds of $ 85.1 million, before the deduction of subscription discounts and commissions and estimated offering costs. In addition, Nyxoah announced today that the syndicate banks in the offering have exercised their option to purchase additional shares in full. The option to purchase additional shares granted to the underwriters was to purchase up to an additional 425,250 new common shares at the public offering price of $ 30 per share, prior to the deduction of subscription discounts and commissions. This move will bring the total gross proceeds of the offering to $ 97.8 million, prior to the deduction of subscription discounts and commissions and estimated offering costs. The exercise of the option to purchase additional shares is expected to be completed on July 9, 2021, subject to the fulfillment of the customary closing conditions.

Piper Sandler, Stifel and Cantor acted as joint book-running managers for the offering. Degroof Petercam acted as co-manager.

A registration statement relating to the common stock was filed with the Securities and Exchange Commission (“SEC”) and was effective June 30, 2021. This press release does not constitute an offer to sell or the solicitation of an offer to buy, if any sale of these securities is made in any state or jurisdiction in which such offer, solicitation or sale is prior to registration or qualification or Publication of an offer prospectus would be unlawful under the securities laws of such a state or jurisdiction.

The story goes on

Ordinary shares were offered exclusively by means of a prospectus. A copy of the final prospectus can be obtained from Piper Sandler & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, Minnesota 55402, by email at [email protected] or by calling (800) 747-3924 ; Stifel, Nicolaus & Company, Incorporated at Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by phone at (415) 364-2720 or email at [email protected]; or Cantor Fitzgerald & Co. Attention: Capital Markets, 499 Park Avenue, 4th Floor, New York, New York 10022; Email: [email protected]

Forward-Looking Statements
This press release contains certain statements that contain “forward-looking statements” including, but not limited to, statements regarding the financial statements of the shares that will be sold in response to the exercise of the option to purchase additional common shares. Forward-looking statements are based on Nyxoah’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict and that could cause actual results to differ. Forward-looking statements contained in this release speak as of this date and Nyxoah assumes no obligation to update this information unless required by applicable law.

IMPORTANT INFORMATION
No public offer is being made and no one has taken any action that would enable or intend to make a public offer in any country or jurisdiction other than the United States where such an action is required, including Belgium. Belgian investors who are not qualified investors within the meaning of the Belgian law of 11 July 2018 on the public offering of securities and the admission of securities to trading on a regulated market are not entitled to participate in the offer (whether in Belgium or elsewhere ). The transaction to which this press release relates is only available to persons in the member states of the European Economic Area within the meaning of Article 2 (e) of Regulation (EU) 2017/1129 and will only be concluded with them via the prospectus, which is to be published when securities are offered to the public or admitted to trading on a regulated market (the “Prospectus Regulation”) and, in the United Kingdom, investment professionals within the meaning of Article 19 (5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the ” Order “), persons who fall under Article 49 (2), (a) to (d) of the Order, and other persons to whom it can lawfully be communicated. A listing prospectus will be prepared by Nyxoah in accordance with Article 3 of the Prospectus Regulation to allow the new common shares to be issued pursuant to the offer and the exercise of their option to purchase additional common shares by the syndicate banks for trading on Euronext Brussels.

Contacts:
Nyxoah
Fabian Suarez, CFO
[email protected]
+32 (0) 10 22 24 55

Gilmartin group
Vivian Cervantes
[email protected]

attachment